Somatotropin

Phase 2Small molecule

FFederico II University

Somatotropin is one of 97 small molecule programs targeting Turner syndrome. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Turner SyndromeActive, not recruiting

Heart FailureActive, not recruiting

Growth Hormone DeficiencyActive, not recruiting

GrowthActive, not recruiting

Turner SyndromePreclinical

Active, not recruiting

Heart FailurePhase 2

Active, not recruiting

Growth Hormone DeficiencyPhase 2

Active, not recruiting

GrowthPhase 2

Active, not recruiting

Competition

Competitive Landscape

687 competitors in Heart Failure

#DrugCompanyPhaseTrials

Somatotropin

FFederico II University

Phase 2

1 2

Medrol

Pfizer

Preclinical

1 3

LCZ696

Novartis

Preclinical

15 4

Monoferric

PPharmacosmos A/S

Preclinical

5 5

Activase

Zemplar

Coumadin

1 8

Statin

Bristol-Myers Squibb

Preclinical

1 9

Kuvan

BioMarin Pharmaceutical

Preclinical

1 10

Acei/arb

Novartis

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Growth2 trials

Impact of Recombinant Human Growth Hormone on HIV Persistence

Completed·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·Phase 2·NCT03091374·22 enrolled

Pilot Study of Growth Hormon to Treat SMA Typ II and III

Completed·UUniversity Hospital Freiburg·Phase 2·NCT00533221·20 enrolled

Growth Hormone Deficiency1 trial

Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial

Completed·FFederico II University·Phase 2·NCT00591760·56 enrolled

Heart Failure1 trial

Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure

Completed·FFederico II University·Phase 2·NCT01576861·28 enrolled

Turner syndrome1 trial

Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome

Completed·—·N/A·NCT01367834·17 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Somatotropin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Somatotropin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Somatotropin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Federico II University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: FFederico II University

Somatotropin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Growth2 trials

Growth Hormone Deficiency1 trial

Heart Failure1 trial

Turner syndrome1 trial

References

Drug Info

Quick Facts

Related News